We serve Chemical Name:4-(2,4,6-trichlorophenoxy)aniline CAS:26306-61-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(2,4,6-trichlorophenoxy)aniline
CAS.NO:26306-61-6
Synonyms:4-(2,4,6-trichloro-phenoxy)-aniline;2,4,6-Trichlorophenyl-4′-aminophenyl ether;4-(2,4,6-Trichlor-phenoxy)-anilin;ANILINE,p-(2,4,6-TRICHLOROPHENOXY);4-(2,4,6-Trichlorophenoxy)benzenamine;2′,4′,6′-Trichloro-4-aminobiphenyl ether;Amino-chlornitrofen
Molecular Formula:C12H8Cl3NO
Molecular Weight:288.55700
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:369.2ºC at 760 mmHg
Density:1.456g/cm3
Index of Refraction:1.642
PSA:35.25000
Exact Mass:286.96700
LogP:5.60250
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-(2,4,6-trichloro-phenoxy)-aniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Amino-chlornitrofen physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(2,4,6-trichloro-phenoxy)-aniline Use and application,4-(2,4,6-Trichlorophenoxy)benzenamine technical grade,usp/ep/jp grade.
Related News: Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2). 4-(2,4,6-trichlorophenoxy)aniline manufacturer The mode of cooperation between domestic API companies and large international companies can lower the export threshold. 4-(2,4,6-trichlorophenoxy)aniline supplier This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy. 4-(2,4,6-trichlorophenoxy)aniline vendor Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said. 4-(2,4,6-trichlorophenoxy)aniline factory The mode of cooperation between domestic API companies and large international companies can lower the export threshold.
